RecruitingNot ApplicableNCT07173985

Strategies for Optimizing a Mailed FIT Program in Appalachia

Sponsor

Ohio State University Comprehensive Cancer Center

Enrollment

500 participants

Start Date

Jan 20, 2026

Study Type

INTERVENTIONAL

Conditions

Colonic Neoplasms

Summary

The proposed study is examining strategies for optimizing mailed fecal immunochemical test (FIT) programs. In doing so, it will assess the efficacy of two promising strategies, FIT kit materials and patient navigation delivery mode. These strategies may help to improve colorectal cancer screening rates.

Eligibility

Min Age: 45 YearsMax Age: 74 Years

Plain Language Summary

Simplified for easier understanding

This study is testing different strategies to improve participation in a mail-at-home colorectal cancer screening program (FIT — fecal immunochemical test) in rural Appalachian communities, where cancer screening rates are historically lower. Participants receive a home stool test kit by mail. **You may be eligible if...** - You live in an Appalachian county - You had a medical visit at a participating health system in the past two years - You are at average risk for colorectal cancer - You are currently not up to date with colorectal cancer screening guidelines **You may NOT be eligible if...** - No specific exclusion criteria have been listed for this study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALStandard FIT kit

Receive a standard FIT kit

BEHAVIORALEnhanced FIT kit

Receive a enhanced FIT kit that includes a video brochure, disposable gloves, and a disposable stool collection device

BEHAVIORALTelephone patient navigation

Receive telephone-based patient navigation

BEHAVIORALText message patient navigation

Receive text message-based patient navigation

Locations(1)

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07173985

Related Trials

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

NCT068856971 location

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

NCT05855200266 locations